Does Semaglutide Cause Hair Loss? Label Numbers, the 2026 BMJ Study, Why It Happens and When It Grows Back

Written by Dr. Diana Munteanu. Updated October 27, 2026.

Semaglutide is associated with hair loss, and the association is now documented in three different kinds of evidence: the Wegovy label, where 3% of trial participants reported hair loss against 1% on placebo; a 2026 study in The BMJ of more than 24,000 people with type 2 diabetes, in which those starting a GLP-1 drug were 37% to 68% more likely to be diagnosed with hair loss than those starting other diabetes drugs; and a 2024 Canadian analysis in which semaglutide users had about one and a half times the hair-loss rate of people on an older weight-loss drug, with women affected twice as often as men. What none of that evidence shows is semaglutide attacking hair follicles. The pattern in every dataset is the same as after bariatric surgery or a crash diet: diffuse shedding that begins two to four months after rapid weight loss starts, peaks, and regrows once the pace slows and nutrition catches up.

This article puts the numbers side by side, explains the mechanism, gives the timeline, lists the blood tests worth asking for, and sets out what helps and what does not. It is specific to semaglutide; tirzepatide shows a somewhat higher rate because its weight loss is larger, and the comparison is included for context.

Hair loss was never a planned outcome of the semaglutide trials; it was recorded when participants mentioned it, so the trial figures are likely undercounts. The real-world studies capture diagnoses in medical records, which undercount in a different way, since most people do not see a doctor about shedding. Taken together they are consistent.

The Ozempic row is the most useful for understanding the mechanism. The same molecule at a lower dose, in people who lose about a third as much weight, does not produce enough hair loss to make the label. The dose is not what sheds hair; the weight loss is. The dose ladder for each product is in our semaglutide dosage chart.

The largest analysis to date came from the University of Pennsylvania and was published in The BMJ in 2026. Researchers followed adults with type 2 diabetes in the Penn health system from 2019 to 2024 who started one of three drug classes: a GLP-1 receptor agonist (mainly Ozempic and Mounjaro), an SGLT2 inhibitor such as Jardiance, or a DPP-4 inhibitor such as Januvia. Compared with 15,221 SGLT2 inhibitor starters, the 12,004 GLP-1 starters were 37% more likely to receive a hair-loss diagnosis; compared with 11,238 DPP-4 inhibitor starters, 68% more likely. The association held across ages and sexes. The authors proposed the same explanation as the dermatology literature: hair loss as a downstream effect of rapid metabolic change rather than a direct action on the follicle. The limitations are the usual ones for health-record studies, including that only people who sought care for hair loss were counted and that people on GLP-1 drugs may differ in ways the analysis could not adjust for.

Scalp hairs cycle through a growth phase of two to six years, a short transition and a resting phase of about three months, at the end of which the hair is shed and a new one grows. Normally 10 to 15% of hairs are resting. A metabolic shock, a large calorie deficit, surgery, childbirth, severe illness or a thyroid swing, pushes a much larger fraction into rest at once. Because resting hairs take about three months to fall, nothing is visible for a while; then a person who has been losing weight steadily since the spring finds the drain full in late summer. The trigger with semaglutide is the size and speed of the deficit and, in many people, a sharp drop in protein, iron and zinc intake as appetite disappears, since protein-rich foods are often the first thing people stop eating. Losing fat also lowers estrogen in women and shifts the balance of hormones that act on hair, which can unmask hereditary thinning that was already under way and would have appeared anyway over the following years. The same deficit is responsible for the fatigue and muscle loss covered in does semaglutide make you tired and does semaglutide cause muscle loss.

The clock runs from when weight loss becomes rapid, which on Wegovy is usually month three or four when the 1.7 and 2.4 mg doses arrive. On Ozempic at 0.5 or 1 mg, where loss is slower, many people never shed noticeably. Where the loss happens in the overall weight curve is shown in how long semaglutide takes to work.

Stopping does not help the hair that is already scheduled to fall, because those follicles entered the resting phase months ago, and it reliably brings the weight back, after which a second round of loss would shed hair again. Switching to tirzepatide does not help either: its trials recorded about 5% hair loss against semaglutide's 3%, because the weight loss is larger, and the trigger is identical. What does help is a dose pause or step-down to slow the loss while nutrition catches up, which prescribers do routinely for people shedding heavily. If you are switching drugs for other reasons, the practicalities are in switching from semaglutide to tirzepatide. People on compounded semaglutide face an extra unknown, since the dose and therefore the pace of loss may not be what the label says; see compounded semaglutide reviews.

Semaglutide causes hair loss in the way any method of losing weight quickly does: by pushing a large share of hair follicles into their resting phase at once. The label puts it at 3% versus 1% on placebo; the 2026 BMJ study and the 2024 Canadian analysis confirm the association in real patients and show women are affected more. The drug does not damage follicles, the shedding arrives on a predictable two-to-four-month delay, and it grows back in almost everyone once the rate of loss slows and protein, iron and other nutrients are adequate. The right response is to pace the loss, eat protein first and check the blood tests that rapid weight loss most often disturbs, not to stop a drug that is working. Everything else the trials recorded is on our semaglutide side effects page, and the mechanism of the weight loss itself is in how semaglutide works.

General information based on published trials and labels. Hair loss with an unusual pattern should be assessed by a dermatologist.